NCT00834223

A Prospective, Multicenter, Open-label, Safety and Preliminary Efficacy Study of the Surgical Implantation of OPKO's Glaucoma Drainage Device (AquashuntTM) in Patients With Refractory Chronic Forms of Open Angle Glaucoma (OAG)

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 15 (actual)
• Sponsor: OPKO Health, Inc. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

A prospective, multicenter, open-label, safety and preliminary efficacy study of the surgical implantation of OPKO's glaucoma drainage device (AquashuntTM) in patients with refractory chronic forms of open angle glaucoma (OAG). The primary objective of this study is to evaluate the surgical implantation, safety and preliminary efficacy of the AquashuntTM after implantation in patients with refractory chronic forms of OAG

Conditions

• Glaucoma

Interventions

Type	Name	Description
DEVICE	Aquashunt	A shunt which is implanted into the suprachoroidal space.

Timeline

• Start date: 2009-01-01
• Primary completion: 2009-09-01
• Completion: 2010-05-01
• First posted: 2009-02-03
• Last updated: 2011-04-01

Locations

1 site across 1 country: Dominican Republic